NASDAQ:SNNA Sienna Biopharmaceuticals (SNNA) Stock Price, News & Analysis → POTUS in ‘25 Not Biden/Trump, But (From The Freeport Society) (Ad) Free SNNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.11▼$0.1750-Day Range$0.14▼$0.1452-Week Range$0.06▼$3.80Volume13.32 million shsAverage Volume1.87 million shsMarket Capitalization$4.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sienna Biopharmaceuticals alerts: Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Sienna Biopharmaceuticals Stock (NASDAQ:SNNA)Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.Read More Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. SNNA Stock News HeadlinesMay 24 at 2:43 AM | msn.comSienna Miller Recalls 'Chaos' Surrounding Her Public Romance With Jude LawMay 23 at 11:42 AM | juniorminingnetwork.comSienna Acquires the "Case Lake West Cesium and Spodumene Pegmatite Project" in OntarioMay 23 at 11:42 AM | msn.comSienna buys Case Lake West Cesium and Spodumene Pegmatite projectMay 23 at 1:17 AM | msn.comSienna Miller Is The Ultimate Female Power PlayerMay 22 at 8:06 PM | msn.comPrincess Beatrice gives hint at sweet bedtime ritual with daughter Sienna as she pays surprise visit to schoolchildrenMay 22 at 10:02 AM | msn.comRare family moments at Cannes Film Festival: Sienna Miller's daughter, Richard Gere's son, moreMay 21 at 7:46 PM | yahoo.comSienna Miller’s Daughter Marlowe Appears on Cannes' Red CarpetMay 21 at 2:30 PM | msn.comHollyoaks confirms arrest twist for Sienna Blake as much-loved resident is brutally attackedMay 21 at 2:30 PM | msn.com2024 Toyota Sienna: A Trim ComparisonMay 20, 2024 | msn.comBarrel Jeans Just Got The Sienna Miller Treatment At The Cannes Film FestivalMay 20, 2024 | msn.comInside the ultra-luxe Maldivian hotel where Sienna Miller babymooned: $3K-per-night villa, tree houses, hypnobirthing classesMay 20, 2024 | msn.comSienna Miller and Daughter Marlowe Have Sweet Red-Carpet Moment in CannesMay 20, 2024 | msn.comSienna Miller's Daughter Marlowe Sturridge Makes Cannes Red Carpet Debut for ‘Horizon' Premiere in Complementary Whimsical LookMay 20, 2024 | yahoo.comSienna Miller Says ‘Magical’ Babymoon Was Her 1st Vacation Ever With Boyfriend Oli GreenMay 20, 2024 | msn.comSienna Miller’s daughter Marlowe Sturridge makes her red-carpet debut at CannesMay 20, 2024 | msn.comSienna Miller walks the Cannes red carpet with daughter MarloweMay 20, 2024 | msn.comSienna Miller's rarely-seen daughter Marlowe, 11, models tumbling princess hair for red carpet appearanceMay 20, 2024 | mirror.co.ukSienna Miller makes first ever red carpet appearance with daughter Marlowe, 11, and they look so alikeMay 20, 2024 | msn.comSienna Miller Shares Inside Glimpse of Her ‘Babymoon’ in the Maldives: 'It Was Astounding'May 19, 2024 | msn.comSalma Hayek, Sienna Miller and Selena Gomez bring out the glamour for day 6 of Cannes Film Festival – see the photosMay 19, 2024 | msn.com‘Horizon’ Film Launch at 2024 Cannes: Kevin Costner & Sienna Miller Joined by Their Children | Cannes Film Festival 2024, Film Premieres, Kevin Costner Family, Sienna ...May 19, 2024 | forbes.com‘Horizon’: Kevin Costner And Sienna Miller Among Stars On Cannes Red CarpetMay 19, 2024 | msn.comSienna Miller Went From Topless Cowboy to Pantsless Cinderella on the Cannes Red CarpetMay 15, 2024 | finance.yahoo.comSienna Announces May DividendMay 13, 2024 | msn.comThe 2024 Toyota 4Runner vs. Toyota SiennaSee More Headlines Receive SNNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sienna Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2019Today5/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SNNA CUSIPN/A CIK1656328 Webwww.siennabio.com Phone(818) 629-2256FaxN/AEmployees39Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,470,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-177.36% Return on Assets-52.22% Debt Debt-to-Equity RatioN/A Current Ratio15.27 Quick Ratio15.27 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.27 per share Price / Book0.11Miscellaneous Outstanding Shares30,908,000Free FloatN/AMarket Cap$4.20 million OptionableNot Optionable Beta2.67 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesFrederick C. BeddingfieldPresident, Chief Executive Officer & DirectorMajed KheirVice President-OperationsPaul F. LizzulChief Medical OfficerSilvio TraversaChief Scientific OfficerTodd J. HarrisDirector & Head-Corporate DevelopmentKey CompetitorsExicureNASDAQ:XCURAtrecaNASDAQ:BCELAlzamend NeuroNASDAQ:ALZNNexImmuneNASDAQ:NEXIEvoke PharmaNASDAQ:EVOKView All Competitors SNNA Stock Analysis - Frequently Asked Questions How were Sienna Biopharmaceuticals' earnings last quarter? Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) announced its earnings results on Thursday, March, 14th. The company reported ($0.93) EPS for the quarter, missing analysts' consensus estimates of ($0.83) by $0.10. What other stocks do shareholders of Sienna Biopharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sienna Biopharmaceuticals investors own include SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), Spectrum Pharmaceuticals (SPPI), Selecta Biosciences (SELB), Viking Therapeutics (VKTX), Novavax (NVAX), Synergy Pharmaceuticals (SGYP), Zealand Pharma A/S (ZEAL) and Bausch Health Companies (BHC). When did Sienna Biopharmaceuticals IPO? Sienna Biopharmaceuticals (SNNA) raised $64 million in an initial public offering on Thursday, July 27th 2017. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets served as the underwriters for the IPO. This page (NASDAQ:SNNA) was last updated on 5/24/2024 by MarketBeat.com Staff From Our PartnersBiden replacement revealed?Paradigm PressThis could mean the end of the U.S dollar…Colonial MetalsUrgent Nvidia WarningAltimetryGold Set to EXPLODE!Gold Safe ExchangeWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sienna Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.